Filing Flows

Filing Flows › Roivant Sciences (ROIV) › Next earnings date

Roivant Sciences (ROIV) earnings on Nov 9, 2026: what to expect

Roivant Sciences (ROIV) is expected to report earnings on Nov 9, 2026, tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.45 (−$0.59 to −$0.35, 3 estimates) on revenue of $4.1M, against −$0.28 and $1.6M a year ago. It beat the EPS estimate in 100% of the quarters on record; Filing Flows' model gives it a 84% chance of beating next time.

Report dateNov 9, 2026
Days to go1
EPS estimate−$0.45
Revenue estimate$4.1M
Beat rate100%

What to watch

Last quarter (Q1 FY27) the lines that make up revenue grew like this; the report shows whether the trend holds:

Roivant Sciences: revenue lines, growth year over year, Q1 FY27Roivant Sciences: revenue lines, growth year over year, Q1 FY27Revenue-34%

Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.28 on revenue of $805K, against the analysts' −$0.45.

The last report

Roivant Sciences reported revenue of $1.4M for the first quarter fiscal 2027 (-34% Y/Y), net loss $291M. How it makes money → · Every quarter →

Roivant Sciences: EPS against the estimate, last 4 reportsRoivant Sciences: EPS against the estimate, last 4 reportsEstimateReported−$0.30−$0.28Nov 25−$0.31−$0.24Feb 26−$0.35−$0.32May 26−$0.36−$0.34Aug 26
Latest (Aug 26): Estimate −$0.36, Reported −$0.34.

Roivant Sciences' latest quarter

Roivant Sciences, Q1 FY27: revenue $1.4M (-34% year over year), net loss $291M, operating cash flow −$271M. The chart follows the revenue to costs, profit and cash.

Questions

When does ROIV report earnings?

Roivant Sciences is expected to report on Nov 9, 2026.

What are analysts expecting from Roivant Sciences?

EPS of −$0.45 and revenue of $4.1M for the quarter.

Does Roivant Sciences usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.